Provided by Tiger Trade Technology Pte. Ltd.

Perpetuals.com Ltd

1.30
+0.04503.59%
Post-market: 1.300.00000.00%19:38 EST
Volume:85.90K
Turnover:108.41K
Market Cap:10.55M
PE:-0.26
High:1.46
Open:1.21
Low:1.20
Close:1.26
52wk High:8.40
52wk Low:1.13
Shares:8.11M
Float Shares:5.30M
Volume Ratio:1.55
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.9964
EPS(LYR):-4.9964
ROE:-72.52%
ROA:-8.93%
PB:0.44
PE(LYR):-0.26

Loading ...

AVA6207 Overcomes Topoisomerase I Inhibitor Resistance In Vitro and In Vivo with Robust and Tumor-Selective Release of Dual Exatecan and ATR Inhibitor Payloads

GlobeNewswire
·
Nov 19

Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers

GlobeNewswire
·
Oct 26

Perpetuals.com partners with EIM to expand financial markets education

TIPRANKS
·
Oct 20

NASDAQ Trade Halt Volatility Trading Pause at 03:54 Pm

Reuters
·
Oct 20

Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia

GlobeNewswire
·
Oct 15

Perpetuals.com Elects Edward Joseph Mills as Independent Director

Reuters
·
Oct 15

Canton Fair Design Innovation Award 2026 Winners Announced: Zhangxue Motorcycle Takes Supreme Gold

Deep News
·
Oct 11

Perpetuals.com Chief Strategy Officer to Present at LD Micro Annual Main Event

Reuters
·
Oct 09

Perpetuals.com UpsideOnly Registered User Base Reaches 600,000 in 38 Days

Reuters
·
Oct 01

Press Release: Avacta Group Plc: Interim Results for the Six Months to June 30, 2026, and Business Update

Dow Jones
·
Sep 30

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

GlobeNewswire
·
Sep 25

Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial

GlobeNewswire
·
Sep 16

Perpetuals.com reports total assets of $65.2M as of April 30

TIPRANKS
·
Sep 16

Press Release: Perpetuals.com Files Annual Report, Posting Increase in Total Assets to $65 Million and Outlining Strategy to Build an AI-Powered Financial Markets Ecosystem

Dow Jones
·
Sep 16

Perpetuals.com Announces Extraordinary Shareholder Meeting

Reuters
·
Sep 16

Press Release: Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee

Dow Jones
·
Sep 14

Vishay Intertechnology XClampR® Bidirectional Flat Clamping TVS in DO-218AC Package Deliver Low Clamping Voltage, High Power Density

GlobeNewswire
·
Sep 10

Perpetuals Says UpsideOnly User Base Tops 400,000

Reuters
·
Sep 02

Perpetuals.com Expects Late Filing of Annual Form 20-F Report for FY Ended April 30, 2026

Reuters
·
Sep 01

Perpetuals.com Says UpsideOnly No-Loss Trading Platform Tops 300,000 Users

Reuters
·
Aug 19